Larvol Delta - Brenig-Therapeutics-to-Present-Phase-1-Data-for-BT267-at-the-American-Academy-of-Neurology-AAN-2026-Annual-Meeting

BT-267 - Brenig Therap

BT-409 - Brenig Therap

https://www.prnewswire.com/news-releases/brenig-therapeutics-to-present-phase-1-data-for-bt-267-at-the-american-academy-of-neurology-aan-2026-annual-meeting-302744511.html

Apr 16, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next